chr12-7128260-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031491.4(RBP5):c.232G>T(p.Val78Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031491.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250058Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135142
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1460920Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726736
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.232G>T (p.V78L) alteration is located in exon 2 (coding exon 2) of the RBP5 gene. This alteration results from a G to T substitution at nucleotide position 232, causing the valine (V) at amino acid position 78 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at